Jagadishwar Pharmaceuticals Latest Annual Report

Unlisted Deals:

ador powertron 500.00 (4,900.00 %) aitmc formerly avpl 62.00 (-6.06 %) amol minechem 601.00 (0.17 %) anglo french drugs 950.00 (2.15 %) anugraha valve 525.00 (2.94 %) apl metals 39.00 (-2.50 %) apollo fashion 90.00 (-2.17 %) arohan 250.00 (-1.96 %) assam carbon 330.00 (1.54 %) avalokiteshvar 242.00 (0.83 %) axles india 655.00 (-3.68 %) balmer lawrie 200.00 (-0.99 %) bharat hotels 380.00 (-1.30 %) bima mandi 235.00 (-2.08 %) bira 545.00 (-0.91 %) blsx limited 35.00 (2.94 %) boat 1,600.00 (3.23 %) c & s electric 1,070.00 (1.90 %) cable corporation 11.00 (-8.33 %) capgemini 14,300.00 (-1.38 %) care health 180.00 (-2.17 %) carrier aircon 550.00 (0.92 %) cial 455.00 (-2.15 %) csk 188.00 (-1.05 %) dalmia refract 270.00 (-1.82 %) dfm foods 470.00 (0.64 %) dsp merrill lynch 1,000.00 east india pharma 39.00 (-2.50 %) eaton fluid 445.00 (1.14 %) electronica plastic 4,500.00 (2.27 %) elgi ultra 400.00 elofic industries 2,850.00 (1.79 %) esl steel 42.00 (-2.33 %) fincare business 87.00 (1.16 %) fincare sfbl 205.00 (1.49 %) finopaytech limited 149.00 (-0.67 %) frick india 3,350.00 (-1.47 %) gkn driveline 1,818.00 (1.00 %) goodluck defence 290.00 (3.57 %) group pharma 300.00 gynofem healthcare 75.00 (2.74 %) hazira cargo terminals limited 205.00 (1.49 %) hdb financial 1,220.00 (-0.41 %) hdfc ergo 370.00 (1.70 %) hdfc securities 10,600.00 (-0.93 %) hella india 900.00 (-2.17 %) hero fincorp 1,950.00 (-0.76 %) hexaware 990.00 (1.02 %) hicks 1,650.00 (3.13 %) hinduja leyland 260.00 hira ferro 200.00 (2.56 %) honeywell electrical 7,600.00 (1.33 %) ikf finance 310.00 (-3.13 %) incred financial 10.00 (1.01 %) incred holdings 153.00 (-1.29 %) india carbon 1,100.00 (-1.79 %) india exposition 121.00 (0.83 %) indian potash 3,150.00 (1.61 %) indian seamless 195.00 (2.63 %) indo alusys 25.75 (-0.96 %) indofil 1,390.00 (-0.71 %) infinite computer 405.00 (1.25 %) inkel 22.00 (-2.22 %) jana small finance bank 75.00 kel 500.00 (-4.76 %) kial 137.00 (-0.72 %) klm axiva 15.50 (3.33 %) kurlon limited 1,275.00 (1.59 %) lava 42.00 (-1.18 %) mahindra rural mrhfl 100.00 manipal housing 74.00 (2.07 %) manjushree technopack 850.00 (-2.86 %) martin & harris 820.00 (-1.20 %) matrix gas 795.00 (-0.63 %) merino 3,300.00 (1.54 %) minosha 282.00 (0.71 %) mitsubishi heavy 207.00 (-0.48 %) mkcl 425.00 (-2.30 %) mohan meakin 2,300.00 (-4.17 %) mohfl 22.00 (4.76 %) msei 4.50 (-5.26 %) msil 34.00 (3.03 %) nayara energy 990.00 (-1.98 %) nayara energy ncd 320.00 (1.59 %) ncdex 199.00 (-1.49 %) ncl buildtek 320.00 (3.23 %) ncl holdings 106.00 (0.95 %) nsdl 1,000.00 (-0.99 %) nse india 1,800.00 (-2.70 %) onix renewable 21,000.00 (2.44 %) orbis financial 420.00 (2.44 %) oswal minerals 60.10 (-1.48 %) otis elevator 4,100.00 (2.50 %) oyo rooms 56.00 (1.82 %) panasonic appliances 270.00 (3.05 %) paymate india 500.00 (-1.96 %) pharmeasy 8.60 (1.78 %) pharmed limited 675.00 (2.27 %) philips domestic 625.00 (-2.34 %) philips india 925.00 (-0.54 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 260.00 (-1.89 %) rapido 16,650.00 (0.03 %) rasoi 82,000.00 (2.50 %) reliance gic 530.00 (1.92 %) resins plastics 575.00 (2.68 %) ring plus aqua 580.00 (3.57 %) rrp s4e innovation 295.00 (-1.67 %) sab miller 535.00 (0.94 %) sbi amc 2,625.00 (-0.19 %) sbi general insurance 621.00 (0.16 %) scottish assam 505.00 (1.00 %) shriram life 261.00 (0.38 %) sigachi laboratories 36.00 (-2.70 %) signify 1,325.00 (-1.85 %) smile microfinance 51.00 (-1.92 %) sterlite grid 5 290.00 (5.45 %) sterlite power 625.00 (0.81 %) studds 1,390.00 (-0.71 %) svsml 315.00 (2.94 %) t stanes 800.00 (1.27 %) tata capital 880.00 (1.15 %) trl krosaki 1,730.00 (-1.14 %) urban tots 64.00 (-1.54 %) utkarsh coreinvest 285.00 (-1.72 %) vikram solar 440.00 (-0.45 %) vivriti capital 1,040.00 (-0.95 %)

Jagadishwar Pharmaceuticals Works Limited (Jagadishwar Pharma) Return Comparision with Primex 40 Index

Periods	1 Week	1 Month	3 Months	6 Months	1 Year	3 Years	All Time
Primex-40
Jagadishwar Pharmaceuticals Works Limited

Jagadishwar Pharmaceutical Works Limited Balance Sheet (Rs In rs.)

Particulars	31-03-2022	31-03-2021
Assets
Non-Current Assets
Investments	12,95,94,147.54	130230881.07
Other Non-Current Assets	415021.00	247369.00
Current Assets
Inventories	4,30,28,802.04	4,29,09,773.80
Cash and Cash Equivalents	64,70,981.65	8,30,259.57
Loans	4,76,97,794.00	7,17,82,439.00
Other Current Assets	8,13,72,287.40	6,22,77,287.40
Total Assets	30,85,79,033.63	308278009.84
Equity & Liabilities
Equity
Share Capital	29,70,01,900.00	297001900.00
Other Equity	1,15,67,373.63	1,12,66,349.84
Liabilities
Current Liabilities
Other Liabilities	9,760.00	9,760.00
Total Equity and Liabilities	30,85,79,033.63	308278009.84

Jagadishwar Pharmaceutical Works Limited Profit & Loss Statement (Rs In rs.)

Particulars	31-03-2022	31-03-2021
Revenue from operations	1,84,500.00	3,50,80,085.00
Other income	50,61,221.00	56,59,916.00
Total Income	52,45,721.00	4,07,40,001.00
Purchase	3,03,528.00	5,38,720.00
Changes in inventory of Finished Goods	-1,19,028.24	3,64,11,570.00
Employee benefit expenses	20,19,188.00	15,19,490.00
Other expenses	17,65,805.92	10,32,903.00
Total expenses	39,69,493.68	3,95,02,683.00
Profit before tax	12,76,227.32	12,37,318.00
Tax Expense for Current Year	3,38,470.00	3,35,360.00
Profit/(loss) for the year	9,37,757.32	9,01,958.00
Items that will not be reclassified to profit or loss-Actuarial (Loss)/Gain	-6,36,733.53	4,35,090.02
Other Comprehensive Income	-6,36,733.53	4,35,090.02
Total Comprehensive Income for the Year	3,01,023.79	13,37,048.02
Earnings per Equity Share
Basic and Diluted	0.38	0.03

Jagadishwar Pharmaceutical Works Limited Consolidated Cash Flow Statement (Rs In rs.)

Particulars	31-03-2022	31-03-2021
Cash flows from operating activities
Net Profit/(loss) before Taxation	12,76,227.32	12,37,318.00
Adjustments for:	-	-
Interest income	-50,61,221.00	-56,59,916.00
Operating profit before working capital changes	-37,84,993.68	-44,22,598.00
Adjustment for :
Change in Inventories	-119028.24	36411570
Change in Other Current Liabilities	-	-2,740.00
Change in Financial Loans	24084645	-4,52,76,440.00
Change in Other Current Assets	-1,90,95,000.00	-3,39,50,000.00
Changes in working capital	48,70,616.76	-42817610.00
Cash Generated from Operations	10,85,623.08	-47240208.00
Income Tax Paid	-5,06,122.00	-356859.00
Net cash from operating activities	5,79,501.08	-47597067.00
Cash flows from investing activities	-	-
- Adjustment for :-
Non Current Financial Assets	-	42204520.5
Interest Income	5061221	5659916
Net cash generated by investing activities	5061221.00	47864436.50
Net increase/(decrease) in cash and cash equivalents	56,40,722.08	267369.50
Cash and cash equivalents at the beginning of the year	830259.57	562890.07
Cash and cash equivalents at the end of the year	64,70,981.65	830259.57

Here is a summary of the Cash Flow Statement for the years 2022 and 2021:

Operating Activities:

Net Profit Before Taxation: The net profit before taxation increased from 12,37,318.00 in 2021 to 12,76,227.32 in 2022, indicating improved profitability.

Interest Income: There was a significant decrease in interest income from -56,59,916.00 in 2021 to -50,61,221.00 in 2022.

Operating Profit Before Working Capital Changes: There was a decrease in operating profit before working capital changes from -44,22,598.00 in 2021 to -37,84,993.68 in 2022.

Changes in Working Capital: There was a positive change in working capital, with cash generated from operations increasing from -4,72,40,208.00 in 2021 to 10,85,623.08 in 2022.

Income Tax Paid: Income tax paid increased from -3,56,859.00 in 2021 to -5,06,122.00 in 2022.

Investing Activities:

There is no information provided for investing activities in both years.

Cash and Cash Equivalents:

Net Increase/(Decrease) in Cash: The net increase in cash and cash equivalents was significant, rising from 2,67,369.50 in 2021 to 56,40,722.08 in 2022.

Cash and Cash Equivalents at the Beginning and End of the Year: The cash and cash equivalents at the beginning of the year were 5,62,890.07 in 2021 and increased to 8,30,259.57 in 2022. By the end of the year, cash and cash equivalents rose to 64,70,981.65 in 2022 from 8,30,259.57 in 2021.

In summary, in 2022, the company experienced improved profitability with an increase in net profit before taxation. Despite a decrease in interest income and operating profit before working capital changes, there was a positive change in working capital, resulting in cash generated from operations. This led to a significant increase in cash and cash equivalents compared to the previous year. Additionally, there were no significant investing activities reported for both years.

Financial Ratios: N/A

Dividend History of Jagadishwar Pharmaceutical Works Limited

PARTICULARS	2022	2021
Dividend Per Share	-	-
Retained Earnings (In Rs.)	47,42,454.09	38,04,696.77

Jagadishwar Pharmaceuticals Annual Report

Jagadishwar Pharmaceuticals Annual Report 2021-22

Download

Jagadishwar Annual Reports, Balance Sheet and Financials

Jagadishwar Pharmaceuticals Works Limited (Jagadishwar Pharma) Return Comparision with Primex 40 Index

Jagadishwar Pharmaceutical Works Limited Balance Sheet (Rs In rs.)

Jagadishwar Pharmaceutical Works Limited Profit & Loss Statement (Rs In rs.)

Jagadishwar Pharmaceutical Works Limited Consolidated Cash Flow Statement (Rs In rs.)

Financial Ratios: N/A

Dividend History of Jagadishwar Pharmaceutical Works Limited

Jagadishwar Pharmaceuticals Annual Report

Jagadishwar Pharmaceuticals Annual Report 2021-22

Most Searched Unlisted & Pre IPO Companies Stocks in India

HDB Financial

NSE India

BIRA

Capgemini

Hero Fincorp

Nayara Energy

OTIS Elevator

Sterlite Power

Care Health

PharmEasy

Philips India

Hexaware

Vikram Solar

Reliance GIC

OYO Rooms

BOAT

Tata Capital

SBI AMC

Swiggy Limited

Waree Energies

Rapido

Incred Holdings

News Alert